Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
7
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 7 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Cosentyx Sensoready (2 Pens) Secukinumab | D | $818M | -4% | 14,195 | $57,596 | $3,543.08 |
| Cosentyx Unoready Pen Secukinumab | D | $378M | +1866% | 6,469 | $58,411 | $3,705.60 |
| Cosentyx Sensoready Pen Secukinumab | D | $248M | +21% | 4,582 | $54,188 | $7,269.28 |
| Cosentyx (2 Syringes) Secukinumab | D | $83.5M | +0% | 1,642 | $50,871 | $3,594.22 |
| Cosentyx Secukinumab · J3247 | B | $54.2M | n/a | 3,236 | $16,757 | $17.24 |
| Cosentyx Syringe Secukinumab | D | $34.2M | +21% | 696 | $49,113 | $7,268.77 |
| Cosentyx Secukinumab | D | $1.1M | n/a | 60 | $18,892 | $418.27 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.